Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

NCT04742595 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Symptomatic COVID-19 Infection Laboratory-Confirmed

Interventions

BIOLOGICAL: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes

Sponsor

M.D. Anderson Cancer Center